Home / Central Data Catalog / FRESH-PEF60166-EN
central

Study of Th2/Th17 balance during allergic bronchopulmonary aspergillosis

France, 2012 - 2014
Reference ID
FRESH-PEF60166-en
Producer(s)
Antoine;MAGNAN
Metadata
DDI/XML JSON
Study website Interactive tools
Created on
Feb 18, 2026
Last modified
Feb 18, 2026
Page views
36
  • Identification
  • Scope
  • Coverage
  • Producers and sponsors
  • Study authorization
  • Sampling
  • Survey instrument
  • Data collection
  • Study activities
  • Data Access
  • Contacts

    • Identification

    Survey ID number

    FRESH-PEF60166-en
    Title

    Study of Th2/Th17 balance during allergic bronchopulmonary aspergillosis
    Abbreviation or Acronym

    TARC-ABPA
    Country
    Name Country code
    France fr
    Kind of Data

    ['Clinical data','Biological data','Participant-reported health data']
    Unit of Analysis

    Individuals

    Scope

    Topics
    Topic Vocabulary
    Pulmonary medicine health theme
    Allergology health theme
    Aspergillosis cim-11
    Biological determinants: Genetic predisposition health determinant
    Biological determinants health determinant
    Keywords
    allergic bronchopulmonary aspergillosis exacerbations biomarkers

    Coverage

    Geographic Coverage

    ['Pays de la Loire']
    Universe

    {"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"ABPA diagnostic: total IgE superior to 417 KU/L immediat hypersensitivity to Aspergillus (positive prick-test and/or positive specifics ige) proximal DDB (bronchiectasis) and/or labile infiltrate (ABPA-S) positives anti-aspergillosis precipitins. Patients pre-included : legally adults, either gender; members of a social security system, obligatory informed and written consent, carriers of an ABPA with all the criteria set out hereinafter, at least once in their medical file; patients without exacerbation since V0 or V0', allowing the definition of a basic status.","clusion_E":""}

    Producers and sponsors

    Primary investigators
    Name
    Antoine;MAGNAN
    Producers
    Name Role
    CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES sponsor
    Funding Agency/Sponsor
    Name
    ARS PAYS DE LA LOIRE
    INSTITUT DE RECHERCHE EN SANTE RESPIRATOIRE DES PAYS DE LA LOIRE (IRSBPL)

    Study authorization

    Agency
    Agency name
    CPP

    Sampling

    Sample frame

    Unit Type

    ['Through organizations (health services or institutions, schools, businesses, etc.)']
    Sampling Procedure

    ['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']

    Survey instrument

    Questionnaires

    Access on specific project only
    Methodology notes

    Observational Study

    Data collection

    Dates of Data Collection
    Start End
    2012-01-01 2014-01-01
    Mode of data collection
    • {"concept":{"vocabURI":"SelfAdministeredQuestionnaire","vocab":"CESSDA"},"value":"Self-administered questionnaire"}
    • {"concept":{"vocabURI":"Interview","vocab":"CESSDA"},"value":"Interview with the participant (including clinical)"}

    Study activities

    Study activities
    Type
    primary evaluation
    Description
    Health event/morbidity

    Data Access

    Availability Status

    {"value":"Restricted access","extLink":[{"title":"COAR","uri":"http://purl.org/coar/access_right/c_16ec"}]}
    Restrictions

    Data utilization by academic teams te be determined. Data utilization not available for industry sectors.

    Contacts

    Contacts
    Name Email
    Antoine;MAGNAN a.magnan@hopital-foch.com
    Back to Catalog